Department of Biochemistry, University of Zurich, Winterthurer Str. 190, CH-8057, Zurich, Switzerland.
Nat Commun. 2022 May 19;13(1):2798. doi: 10.1038/s41467-022-30479-1.
TMEM16A, a calcium-activated chloride channel involved in multiple cellular processes, is a proposed target for diseases such as hypertension, asthma, and cystic fibrosis. Despite these therapeutic promises, its pharmacology remains poorly understood. Here, we present a cryo-EM structure of TMEM16A in complex with the channel blocker 1PBC and a detailed functional analysis of its inhibition mechanism. A pocket located external to the neck region of the hourglass-shaped pore is responsible for open-channel block by 1PBC and presumably also by its structural analogs. The binding of the blocker stabilizes an open-like conformation of the channel that involves a rearrangement of several pore helices. The expansion of the outer pore enhances blocker sensitivity and enables 1PBC to bind at a site within the transmembrane electric field. Our results define the mechanism of inhibition and gating and will facilitate the design of new, potent TMEM16A modulators.
TMEM16A 是一种钙激活氯离子通道,参与多种细胞过程,是高血压、哮喘和囊性纤维化等疾病的潜在治疗靶点。尽管有这些治疗承诺,但它的药理学仍然知之甚少。在这里,我们展示了 TMEM16A 与通道阻滞剂 1PBC 复合物的冷冻电镜结构,并对其抑制机制进行了详细的功能分析。一个位于沙漏形孔颈部区域外部的口袋负责 1PBC 以及可能还有其结构类似物的开放通道阻断。阻断剂的结合稳定了通道的类似开放的构象,涉及几个孔螺旋的重排。外孔的扩张增加了阻断剂的敏感性,并使 1PBC 能够结合在跨膜电场内的一个位点。我们的结果定义了抑制和门控的机制,并将促进新的、有效的 TMEM16A 调节剂的设计。